ArticleHeliyon2022
Noninvasive blood oxygen, heartbeat rate, and blood pressure parameter monitoring by photoplethysmography signals.
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Non-invasive blood pressure monitoring using wearables for cardiovascular risk assessment: a systematic review.Archives of gynecology and obstetrics · 2026Pooled it
- Photoplethysmography-based HRV analysis and machine learning for real-time stress quantification in mental health applications.APL bioengineering · 2025Article
- Enhancing safety with an AI-empowered assessment and monitoring system for BSL-3 facilities.Heliyon · 2025Article
- IoT-Based Hand Hygiene Compliance Monitoring System and Validation of Its Effectiveness in Hospital Environments.Global challenges (Hoboken, NJ) · 2024Article
- Next-Generation swimming pool drowning prevention strategy integrating AI and IoT technologies.Heliyon · 2024Review
- IoT-based wearable health monitoring device and its validation for potential critical and emergency applications.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The popularization of long-term invasive tools for continuously monitoring blood pressure remains challenging. However, with the rising popularity of wearable personal health management devices, non-cuff blood pressure measurement technology that applies electrocardiography (ECG) and photoplethysmography (PPG) has gradually received increasing attention. In particular, whether blood pressure can be measured continuously by the PPG signal alone is of great interest. In this study, we aim to develop a device that includes systolic and diastolic blood pressure calculation formulas derived from characteristic waveform points in the PPG time domain and that can measure blood oxygenation and heart rate. This device applies empirical formulas developed by PPG waveforms in the PhysioNet MIMIC-II database to calculate blood pressure. The systolic and diastolic pressures are then compared with the actual blood pressures obtained from invasive blood pressure waveforms to verify the effectiveness and feasibility of the complete developed system. Overall, 263 waveforms with double peaks and 261 waveforms with only a single peak totaling 524 sets of data are used to derive the empirical formulas. The systolic blood pressure estimation result using single peak analysis has an excessively large error exceeding ±40 mmHg, providing no reference value. However, systolic blood pressure estimation is notably better in double peak analysis, with error values reducing to approximately 23 mmHg. Diastolic pressure estimation errors are low with both single (±7 mmHg) and double peak (±4 mmHg) analyses. The error is lower in double-peak analysis than in single-peak analysis for obtaining systolic pressure from PPG waves. We plan to use PPG to detect additional physiological parameters in the future, e.g., respiratory rate, heart rate variability, or irregular heartbeat, to further enhance the functionality of PPG-based wearable devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.